Todd J. Kohn

Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents

Hilary P. Beck, Todd J. Kohn, Steven M. Rubenstein et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 54 citations · Full text

Medicine, Potent Lpa2, Pharmacological Agent +6

Dibasic Benzo[<i>b</i>]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding Orientation

Daniel J. Sall, Jolie Bastian, John A. Buben et al. · Journal of Medicinal Chemistry · 1997 · 54 citations

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +19

Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

Felix González-López de Turiso, Youngsook Shin, Matthew F. Brown et al. · Journal of Medicinal Chemistry · 2012 · 49 citations · Full text

Pharmaceutical Science, Dual Pi3kβ/δ Inhibitors, Pharmaceutical Chemistry +16

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 48 citations · Full text

New Antidepressants, Psychoactive Drug, Psychiatry +12

Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[b]thiophenes

Kumiko Takeuchi, Todd J. Kohn, Daniel J. Sall et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 35 citations

Medicinal Chemistry, Derivative (Chemistry), Thrombin Inhibitors +10